These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31199010)

  • 21. A comparative study of CSF neurofilament light and heavy chain protein in MS.
    Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
    Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylated Neurofilament Heavy Chain in the Cerebrospinal Fluid Is a Suitable Biomarker of Acute and Chronic Blast-Induced Traumatic Brain Injury.
    Arun P; Rossetti F; Eken O; Wilder DM; Wang Y; Long JB
    J Neurotrauma; 2021 Oct; 38(20):2801-2810. PubMed ID: 34210150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain.
    Petzold A; Shaw G
    J Immunol Methods; 2007 Jan; 319(1-2):34-40. PubMed ID: 17140597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
    Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.
    Ganesalingam J; An J; Shaw CE; Shaw G; Lacomis D; Bowser R
    J Neurochem; 2011 May; 117(3):528-37. PubMed ID: 21418221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.
    Pranzatelli MR; Tate ED; McGee NR; Verhulst SJ
    J Neuroimmunol; 2014 Jan; 266(1-2):75-81. PubMed ID: 24342231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
    Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers.
    Neselius S; Zetterberg H; Blennow K; Marcusson J; Brisby H
    PLoS One; 2013; 8(11):e81249. PubMed ID: 24260563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multi-center study of neurofilament assay reliability and inter-laboratory variability.
    Gray E; Oeckl P; Amador MDM; Andreasson U; An J; Blennow K; Bowser R; De Schaepdryver M; Heslegrave A; Kuhle J; Maceski A; Koel-Simmelink M; Lamari F; Lombardi V; Malaspina A; Nilsson I; Poesen K; Salachas F; Steinacker P; Teunissen CE; Van Damme P; Zetterberg H; Ludolph A; Jeromin A; Turner MR; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):452-458. PubMed ID: 32558597
    [No Abstract]   [Full Text] [Related]  

  • 34. Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients.
    Faravelli I; Meneri M; Saccomanno D; Velardo D; Abati E; Gagliardi D; Parente V; Petrozzi L; Ronchi D; Stocchetti N; Calderini E; D'Angelo G; Chidini G; Prandi E; Ricci G; Siciliano G; Bresolin N; Comi GP; Corti S; Magri F; Govoni A
    J Cell Mol Med; 2020 Mar; 24(5):3034-3039. PubMed ID: 32032473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.
    Koel-Simmelink MJ; Vennegoor A; Killestein J; Blankenstein MA; Norgren N; Korth C; Teunissen CE
    J Immunol Methods; 2014 Jan; 402(1-2):43-9. PubMed ID: 24275679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.
    Fialova L; Bartos A; Svarcova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):286-295. PubMed ID: 28947837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
    Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
    Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.